Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1987-12-24
|
pubmed:abstractText |
Fusion of MHV-3-immune splenocytes from MHV-3-resistant A/J murine strain, with NS myeloma cells produced several hybridomas. Among eight hybridoma clones, the 1E7A4H1 clone secreted kappa IgG2a apparently directed against the nucleoprotein of the MHV-3 virion. The monoclonal antibody was able to neutralize the in vitro cytopathic effect of MHV-3 on cultured L2 cells, and was detected by indirect immunofluorescence on MHV-3-infected cultured YAC cells. In addition, it conferred a significant protection against MHV-3-induced acute disease, if injected intraperitoneally to C57BL/6 mice before inoculation with MHV-3.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0304-8608
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
123-30
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2825619-Animals,
pubmed-meshheading:2825619-Antibodies, Monoclonal,
pubmed-meshheading:2825619-Antibody Specificity,
pubmed-meshheading:2825619-Antigens, Surface,
pubmed-meshheading:2825619-Cytopathogenic Effect, Viral,
pubmed-meshheading:2825619-Hepatitis, Viral, Animal,
pubmed-meshheading:2825619-Liver,
pubmed-meshheading:2825619-Mice,
pubmed-meshheading:2825619-Mice, Inbred A,
pubmed-meshheading:2825619-Murine hepatitis virus,
pubmed-meshheading:2825619-Neutralization Tests,
pubmed-meshheading:2825619-Nucleoproteins,
pubmed-meshheading:2825619-Viral Proteins
|
pubmed:year |
1987
|
pubmed:articleTitle |
Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Brief report.
|
pubmed:affiliation |
Institut Armand-Frappier, Centre de recherche en virologie, Québec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|